Moors & Cabot, Inc. Abbott Laboratories Transaction History

Moors & Cabot, Inc.

$1.96 Billion
Q3 2024

A detailed history of Moors & Cabot, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Moors & Cabot, Inc. holds 60,129 shares of ABT stock, worth $6.93 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

60,129

Previous 58,419 2.93%

Holding current value

$6.93 Million

Previous $6.07 Million 12.93%

% of portfolio

0.35%

Previous 0.33%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $171,119 - $202,002	1,710 Added 2.93%	60,129 $6.86 Million
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $124,603 - $139,088	1,237 Added 2.16%	58,419 $6.07 Million
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $15,223 - $16,813	139 Added 0.24%	57,182 $6.5 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $31,656 - $38,750	-351 Reduced 0.61%	57,043 $6.28 Million
Q3 2023 Nov 07, 2023	SELL	$95.53 - $114.62 $42,510 - $51,005	-445 Reduced 0.77%	57,394 $5.56 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $47,870 - $53,337	-475 Reduced 0.81%	57,839 $6.31 Million
Q1 2023 May 04, 2023	SELL	$96.86 - $114.01 $8,426 - $9,918	-87 Reduced 0.15%	58,314 $5.9 Million
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $321,873 - $377,606	3,386 Added 6.15%	58,401 $6.41 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $429,671 - $504,070	-4,520 Reduced 7.59%	55,015 $6.04 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $319,404 - $369,811	-3,301 Reduced 5.25%	59,535 $5.76 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $58,996 - $71,307	-578 Reduced 0.91%	62,836 $6.83 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $423,926 - $516,950	3,718 Added 6.23%	63,414 $7.51 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $71,628 - $87,705	-620 Reduced 1.03%	59,696 $8.4 Million
Q3 2021 Dec 08, 2021	BUY	$116.66 - $129.06 $7.04 Million - $7.78 Million	60,316 New	60,316 $7.13 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $6.9 Million - $7.63 Million	-59,144 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $79,871 - $94,020	755 Added 1.29%	59,144 $6.86 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $182,524 - $215,041	-1,677 Reduced 2.79%	58,389 $7 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $193,725 - $211,104	-1,845 Reduced 2.98%	60,066 $6.58 Million
Q3 2020 Nov 09, 2020	BUY	$91.64 - $111.29 $73,678 - $89,477	804 Added 1.32%	61,911 $6.74 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $730,324 - $934,724	9,538 Added 18.5%	61,107 $5.59 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $600,056 - $877,446	-9,552 Reduced 15.63%	51,569 $4.08 Million
Q4 2019 Jan 28, 2020	BUY	$78.51 - $87.4 $112,661 - $125,419	1,435 Added 2.4%	61,121 $5.31 Million
Q3 2019 Oct 22, 2019	BUY	$81.84 - $88.74 $300,762 - $326,119	3,675 Added 6.56%	59,686 $4.99 Million
Q2 2019 Jul 18, 2019	BUY	$72.88 - $85.0 $3,862 - $4,505	53 Added 0.09%	56,011 $4.71 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $3.71 Million - $4.48 Million	-55,958 Reduced 50.0%	55,958 $4.48 Million
Q1 2019 May 01, 2019	BUY	$66.22 - $80.06 $3.59 Million - $4.34 Million	54,258 Added 94.1%	111,916 $8.95 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $166,719 - $188,868	-2,543 Reduced 4.22%	57,658 $4.16 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $256,131 - $308,992	4,212 Added 7.52%	60,201 $4.42 Million
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $344,211 - $379,905	-5,979 Reduced 9.65%	55,989 $3.4 Million
Q1 2018 May 18, 2018	SELL	$56.27 - $63.62 $40,852 - $46,188	-726 Reduced 1.16%	61,968 $3.71 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $79,661 - $85,285	-1,484 Reduced 2.31%	62,694 $3.58 Million
Q3 2017 Nov 16, 2017	BUY	$48.06 - $53.64 $739,979 - $825,895	15,397 Added 31.56%	64,178 $3.42 Million
Q2 2017 Aug 15, 2017	BUY	N/A	48,781	48,781 $2.38 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account